Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Acceptance and Commitment Therapy-Based Chatbot for Non-suicidal Self-Injury in Adolescents: A Randomized Controlled Trial

NCT07848620 is registered in ClinicalTrials.gov with Central China Normal University as lead sponsor.

NCT NCT07848620
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07848620 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Acceptance and Commitment Therapy-Based Chatbot for Non-suicidal Self-Injury in Adolescents: A Randomized Controlled Trial
Lead sponsor
Central China Normal University
Phase
Not applicable
Overall status
Not yet recruiting
Start date
October 8, 2026
Completion date
March 1, 2027
Enrollment
100 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

non-suicidal self-injury (nssi)